Contact: Bachtler, Barbara
Helmholtz Association of German Research Centres
Caption: A research team led by Anna Floegel of the German Institute of Human Nutrition and Tobias Pischon of the Max Delbrueck Center for Molecular Medicine has identified 14 novel biomarkers for type 2 diabetes. They can serve as basis for developing new methods of treatment and prevention of this metabolic disease. The biomarkers can also be used to determine diabetes risk at a very early point in time. At the same time the markers enable insight into the complex mechanisms of this disease, which still have not been completely elucidated. (Diabetes, A. Floegel et al., 2012; DOI 10.2337/db12-0495)*. The researchers studied the blood of study participants from three different studies with respect to their metabolites (metabolomics). The study was based on data and blood samples of the prospective EPIC-Potsdam** study with more than 27,500 study participants, the Tuebingen family study and the KORA study***. The study was conducted in collaboration with the German Center for Diabetes Research (DZD) and funded by the Federal Ministry of Education and Research (BMBF). Sample tubes containing the blood samples of the EPIC-Potsdam study participants.
Credit: Birgit Große/Copyright: DIfE
Usage Restrictions: Photo can only be used indicating photographer and copyright
Related news release: 14 new biomarkers identified for type 2 diabetes